Clinical Trial Update: Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study [Phase 3]

View source ↗

Summary

Phase 3 clinical effectiveness study assessing gabapentin and oxcarbazepine for pediatric chronic neuropathic pain; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Gabapentin (Gabapentin)
• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Pediatric Chronic Neuropathic Pain | Phase 3 | Status: NOT_YET_RECRUITING